EMERADE 300 micrograms, solution for injection in a pre-filled pen 2 pens of 0.3 ml
Active ingredients: Epinephrine, Epinephrine bitartrate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection2 pens of 0.3 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EMERADE 300 microgrammes, solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 2 stylos préremplis en verre de 0,3 mL
- Marketing authorisation holder
- BAUSCH HEALTH IRELAND (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Apr 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69549631CIP73002727CIP133400930027271Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ADRÉNALINEsolution | 300 microgrammes · une dose 0,30 ml | FT |
| TARTRATE D'ADRÉNALINEsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.